Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 2/20 | 0.46 |
| ▸ | CHRNA5 | P30532 | 2/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | CLK4 | Q9HAZ1 | 5/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.45 |
| ▸ | NEK1 | Q96PY6 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | OXTR | P30559 | 1/20 | 0.42 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6846105 | 0.83 | MAPK14 (0.49) | CHRNB2CHRNA5CHRNA4CYP1A2CYP3A4 | |
| SCHEMBL6847772 | 0.82 | DYRK1A (0.47) | CYP1A2CYP3A4HSD17B10ALDH1A1MAPK1 | |
| SCHEMBL6657600 | 0.82 | CYP11B1 (0.43) | CHRNB2CHRNA5CHRNA4CYP1A2CYP3A4 | |
| SCHEMBL6844276 | 0.81 | CDC7 (0.44) | CYP1A2ALDH1A1CYP11B2CYP11B1KDM4E | |
| SCHEMBL6654549 | 0.80 | CYP11B2 (0.53) | CHRNB2CHRNA5CHRNA4CYP1A2CYP3A4 | |
| SCHEMBL6840695 | 0.79 | NPY5R (0.44) | KCNA5KCNH2KDM4E | |
| SCHEMBL6846191 | 0.78 | DHPS (0.50) | CYP1A2CYP3A4ALDH1A1KCNA5KCNH2 | |
| SCHEMBL6665169 | 0.78 | CYP17A1 (0.49) | CYP1A2CYP11B2CYP11B1CYP17A1CYP19A1 | |
| SCHEMBL6657827 | 0.76 | CYP17A1 (0.41) | CYP1A2CYP3A4HSD17B10MAPK1CYP11B2 | |
| SCHEMBL6840527 | 0.76 | S1PR1 (0.47) | CYP1A2CYP3A4HSD17B10CYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040236110-A1 | Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors | BAYER PHARMACEUTICALS CORPORATION | 2004-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040236110-A1 | Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors | CYP17A1, IDO1, CYP21A2 | CHRNB2 3541/4885CHRNA5 2650/4885CHRNA4 4040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.